ACRO Biomedical Co., Ltd. (TPEX:6748)

ACRO Biomedical Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 7, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	4,346	4,040	1,564	2,409	1,024	939
Market Cap Growth	98.60%	158.32%	-35.07%	135.16%	9.09%	-
Enterprise Value	3,379	3,600	1,051	2,150	691	860
Last Close Price	71.00	66.00	25.28	38.94	19.69	24.61
PS Ratio	113.62	105.62	35.36	47.18	37.07	43.02
PB Ratio	3.94	3.66	2.50	3.51	2.71	7.22
P/TBV Ratio	3.96	3.68	2.52	3.56	2.76	7.69
EV/Sales Ratio	88.33	94.11	23.75	42.11	25.01	39.40
Debt / Equity Ratio	0.01	0.01	0.03	0.03	0.03	0.10
Net Debt / Equity Ratio	-0.88	-0.88	-0.77	-0.81	-0.81	-0.38
Net Debt / EBITDA Ratio	11.95	11.95	8.30	12.76	5.27	1.05
Net Debt / FCF Ratio	15.65	15.65	6.54	8.06	6.39	1.03
Asset Turnover	0.04	0.04	0.06	0.09	0.10	0.12
Inventory Turnover	1.69	1.69	1.79	1.09	1.05	0.52
Quick Ratio	49.90	49.90	27.58	39.66	25.82	6.11
Current Ratio	51.12	51.12	28.68	41.04	27.68	9.01
Return on Equity (ROE)	-9.55%	-9.55%	-9.46%	-7.78%	-23.94%	-32.92%
Return on Assets (ROA)	-6.45%	-6.45%	-5.89%	-5.46%	-14.27%	-18.87%
Return on Capital Employed (ROCE)	-8.30%	-8.30%	-10.20%	-6.90%	-16.30%	-38.30%
Earnings Yield	-1.90%	-2.05%	-3.97%	-1.72%	-5.94%	-5.41%
FCF Yield	-1.42%	-1.53%	-4.73%	-2.88%	-4.67%	-5.13%
Buyback Yield / Dilution	0.40%	-0.01%	-16.17%	-11.22%	-33.71%	-17.22%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.